[ad_1]
Differential, or tiered pricing, is when costs are set relying on the GDP of a rustic.
“We will have tiered pricing for middle-income countries (India is considered a middle-income country) and we will give it for free in Africa,” Albert Bourla, CEO of Pfizer, mentioned at a press convention organised by the International Federation of Pharmaceutical Manufacturers and Associations.
In the US, the place the Food and Drug Administration authorised the corporate’s vaccine, Pfizer has set a worth of $19.50 for a single dose.
“This is the price of one meal,” Bourla mentioned, including that Pfizer is in negotiations with governments all over the world.
The mRNA know-how-based mostly vaccine has an efficacy of over 90% with a double dose and 67% with a single dose.
Last week, New York-based Pfizer sought emergency-use approval for its Covid-19 vaccine from Indian regulators. A choice will likely be taken by the Subject Expert Committee within the coming weeks.
Pfizer/BioNTech’s vaccine was developed in file time and launched as a part of the formal vaccination drive by the UK authorities on Tuesday, making it the primary Covid-19 vaccine to be administered anyplace on this planet.
While the vaccine depends on new and secure know-how, the -70C storage requirement may develop into a difficulty in international locations with poor storage services. Pfizer is engaged on one other model of the vaccine that requires much less stringent storage necessities.
While Pfizer has mentioned it should promote its vaccine for revenue, Janssen Pharma, part of Johnson & Johnson, mentioned it should promote its Covid-19 vaccine at value. “We won’t be selling the vaccine for profit as we developed it with multiple partners,” mentioned Paul Stoffels, chief scientific officer, Janssen Pharma.
(This story has not been edited by Newslivenation employees and is auto-generated from a syndicated feed.)